Author

Maria Luisa Faquetti

Observed names: Faquetti, Maria Luisa, Faquetti, Maria Luisa Marques de Sa, M.L. Faquetti, Maria L. Faquetti

Observed institutions: ETH Zurich, Institute of Pharmaceutical Sciences

ORCID: 0000-0002-5990-3322

Observed ORCID: 0000-0002-5990-3322

OpenAlex ID: A5013645247

Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease

2024 · Maria L. Faquetti, Laura Slappendel, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 19

Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection

2022 · Maria L. Faquetti, Francesca Grisoni, et al. · Scientific Reports · 16

Identification of polypharmacy patterns in new‐users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining

2022 · Maria Luisa Faquetti, Adrian Martinez‐De la Torre, et al. · Pharmacoepidemiology and Drug Safety · 10

Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care

2024 · Maria Luisa Faquetti, Géraldine Frey, et al. · British Journal of Clinical Pharmacology · 7

JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register

2023 · Maria Luisa Faquetti, Enriqueta Vallejo-Yagüe, et al. · PLoS ONE · 2

Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate ( ETIE )—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research

2025 · Enriqueta Vallejo‐Yagüe, Sieta T. de Vries, et al. · Pharmacoepidemiology and Drug Safety · 1

Off-target profiling of tofacitinib and baricitinib by machine learning: a focus on thrombosis and viral infection.

2021 · Maria Luisa Faquetti, Francesca Grisoni, et al. · 1

Pos0091 Off-target Profiling of Janus Kinase (jak) Inhibitors in Rheumatoid Arthritis: a Computer-based Approach for Drug Safety Studies and Repurposing

2021 · M.L. Faquetti, F. Grisoni, et al. · Annals of the Rheumatic Diseases · 1

A Structural FHMM for Interpretable Disease Trajectories in T2DM

2026 · Mari, Alessandro, Krymova, Ekaterina, et al. · arXiv (Cornell University)

Examining inappropriate medication in UK primary care for type 2 diabetes patients with polypharmacy

2023 · Maria Luisa Faquetti, Géraldine Frey, et al. · medRxiv

A data-driven approach to identify clusters of HbA1c longitudinal trajectories and associated outcomes in type 2 diabetes mellitus: a large population-based cohort study

2022 · Adrian Martinez-De la Torre, Maria Luisa Faquetti, et al. · medRxiv

Works count: 15

Citation count: 57

H-index: 4

I10-index: 3